Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells

Circulation Research

Volumn 79, Issue 4, 1996, Pages 736-747

  Slowik, Mark R ^a   De Luca, Linda G ^a   Min, Wang ^a   Pober, Jordan S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cell death; ceramide; sphingomyelinase; tumor necrosis factor; vascular endothelial cell

Indexed keywords

CERAMIDE; TUMOR NECROSIS FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ADHESION; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; ENDOTHELIUM CELL; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR UPREGULATION; SECOND MESSENGER; VASCULAR ENDOTHELIUM;

EID: 0029796631     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.4.736     Document Type: Article

References (51)

1. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70:427-451.
2. Cotran RS, Pober JS. Cytokine-endothelial interactions in inflammation, immunity, and vascular injury. J Am Soc Nephrol. 1990;1:225-235.
3. Rothe J, Gehr G, Loetscher H, Lesslauer W. Tumor necrosis factor receptors-structure and function. Immunol Res. 1992;11:81-90.
4. Slowik MR, De Luca LG, Fiers W, Pober JS. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol. 1993;143:1724-1730.
5. Whelan J, Hooft van Huijsduijen R, Gray J, Chandra G, Talabot F, DeLamarter JF. An NFκB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 1991;19:2645-2653.
6. Jademarco MF, Mcquillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem. 1992;267:16323-16329.
7. Voraberger G, Schaffer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. J Immunol. 1991;145:2777-2786.
8. De Luca LG, Johnson DR, Whitely MZ, Collins T, Pober JS. cAMP and tumor necrosis factor competitively regulate transcriptional activation through and nuclear factor binding to the cAMP-responsive element/activating transcription factor element of the endothelial leukocyte adhesion molecule-1 (E-selectin) promoter. J Biol Chem. 1994;269:19193-19196.
9. Gupta S, Campbell D, Derijard B, Davis RJ. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 1995;267:389-393.
10. Dressler KA, Mathias S, Kolesnick RN. Tumor necrosis factor-α activates the sphingomyelin signal transduction pathway in a cell-free system. Science. 1992;255:1715-1718.
11. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem. 1994;269:3125-3128.
12. Mathias S, Dressler KA, Kolesnick RN. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor-α. Proc Natl Acad Sci U S A. 1991;88:10009-10013.
13. Liu J, Mathias S, Yang Z, Kolesnick RN. Renaturation and tumor necrosis factor-αa stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem. 1994;269:3047-3052.
14. Lozano J, Berra E, Municio MM, Diaz-Meco MT, Dominguez I, Sanz L, Moscat J. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem. 1994;269:19200-19202.
15. Dobrowsky RT, Kamibayashi C, Mumby MC, Hannun YA. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem. 1993;268:15523-15530.
16. Dbaibo GS, Pushkareva MY, Jayadev S, Schwarz JK, Horowitz JM, Obeid LM, Hannun YA. Retinoblastoma gene product as a down-stream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci U S A. 1995;92:1347-1351.
17. Okazaki T, Bielawska A, Bell RM, Hannun YA. Role of ceramide as a lipid mediator of 1α,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J Biol Chem. 1990;265:15823-15831.
18. Yang Z, Costanzo M, Golde DW, Kolesnick RN. Tumor necrosis factor activation of the sphingomyelin pathway signals nuclear factor KB translocation in intact HL-60 cells. J Biol Chem. 1993;268:20520-20523.
19. Dbaibo GS, Obeid LM, Hannun YA. Tumor necrosis factor-α (TNF-α) signal transduction through ceramide: dissociation of growth inhibitory effects of TNF-α from activation of nuclear factor-κB. J Biol Chem. 1993;268:17762-17766.
20. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 1993;71:765-776.
21. Wiegmann K, Schutze S, Machiedt T, Witte D, Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 1994;78:1005-1015.
22. Pushkareva M, Obied LM, Hannun YA. Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol Today. 1995;16:294-297.
23. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A. 1987;84:9238-9242.
24. Pober JS, Slowik MR, De Luca LG, Ritchie AJ, Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-I. J Immunol 1993;150:5114-5123.
25. Preiss J, Loomis CR, Bishop WR, Stein R, Niedel JE, Bell RM. Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem. 1986;261:8597-8600.
26. Jayadev S, Linardic CM, Hannun YA. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J Biol Chem. 1994;269:5757-5763.
27. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JO, Smith JA, Struhl K. Short Protocols in Molecular Biology. New York, NY: John Wiley & Sons Inc; 1989:283.
28. Rauscher FJ III, Voulalas PJ, Franza RR Jr, Curran TC. Fos and Jun bind cooperatively to the AP-1 site: reconstitution in vitro. Genes Dev. 1988;2:1687-1699.
29. Min W, Ghosh S, Lengyel P. The interferon-indueible p202 protein as a modulator of transcription: inhibition of NF-κB, c-Fos, and c-Jun activities. Mol Cell Biol. 1996;16:359-368.
30. Smith DB, Johnson KS, Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 1988;67:31-40.
31. Hibi M, Lin A, Smeal T, Minden A, Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 1993;7:2135-2148.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
33. Johnson DR, Pober JS. HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol. 1994;14:1322-1332.
34. Linardic CM, Hannun YA. Identification of a distinct pool of sphingomyelin involved in the sphingomyelin cycle. J Biol Chem. 1994;269:23530-23537.
35. Kim M-Y, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and &-interferon. J Biol Chem. 1991;266:484-489.
36. Pagano RE, Martin OC, Kang HC, Haugland RP. A novel fluorescent ceramide analog for studying membrane traffic in animal cells: accumulation at the Golgi apparatus results in altered spectral properties of the sphingomyelin precursor. J Cell Biol. 1991;113:1267-1279.
37. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress-activated protein kinase sub-family of c-Jun kinases. Nature. 1994;369:156-160.
38. Mathias S, Younes A, Kan C, Orlow I, Joseph C, Kolesnick RN. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science. 1993;259:519-522.
39. Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tarr PI, Bomsztyk K, Lobb R, Harlan JM, PoMman TH. Activation of endothelial leukocyte adhesion molecule I (ELAM-1) gene transcription. Proc Natl Acad Sci U S A. 1991;88:6523-6527.
40. Johns LD, Sarr T, Ranges GE, Inhibition of ceramide pathway does not affect ability of TNF-α to activate nuclear factor-κE. J Immunol. 1994;152:5877-5882,
41. Betts JC, Agranoff AB, Nabel GJ, Shayman JA. Dissociation of endogenous cellular ceramide from NF-κB activation. J Biol Chem. 1994;269:8455-8458.
42. Ritchie AJ, Johnson DJ, Ewenstein BM, Pober JS. Tumor necrosis factor induction of endothelial cell surface antigens is independent of protein kinase C activation or inactivation. J Immunol. 1991;146:3056-3062.
43. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the p75 tumor necrosis factor receptor. Cell. 1994;78:681-692.
44. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J Biol Chem. 1995;270:3574-3581.
45. Rothe M, Sara V, Dixit VM, Goeddel DV. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40, Science. 1995;269:1424-1427.
46. Hsu H, Shu H-B, Pan M-G, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996;84:299-308.
47. Darnay BG, Reddy SAG, Aggarwal BB. Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J Biol Chem. 1994;269:20299-20304.
48. Vanarsdale TL, Ware CF. Ligand-dependent stimulation of a serine protein kinase activity associated with (CD120a) TNFR60. J Immunol. 1994;153:3043-3050.
49. Obeid LM, Linardic CM, Karolak LA, Hannun YA, Programmed cell death induced by ceramide. Science. 1993;259:1769-1771.
50. Jarvis WD, Kolesnick RN, Fomari FA, Traylor RS, Gewirtz DA, Grant S. Induction of apopiotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci U S A. 1994;91:73-77.
51. Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, Hannun YA, Seldin MF. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci U S A. 1995;92:8443-8447.